| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | C20orf3 |
| Uniprot No | Q9HDC9 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-416aa |
| 氨基酸序列 | MSEADGLRQRRPLRPQVVTDDDGQAPEAKDGSSFSGRVFRVTFLMLAVSLTVPLLGAMMLLESPIDPQPLSFKEPPLLLGVLHPNTKLRQAERLFENQLVGPESIAHIGDVMFTGTADGRVVKLENGEIETIARFGSGPCKTRDDEPVCGRPLGIRAGPNGTLFVADAYKGLFEVNPWKREVKLLLSSETPIEGKNMSFVNDLTVTQDGRKIYFTDSSSKWQRRDYLLLVMEGTDDGRLLEYDTVTREVKVLLDQLRFPNGVQLSPAEDFVLVAETTMARIRRVYVSGLMKGGADLFVENMPGFPDNIRPSSSGGYWVGMSTIRPNPGFSMLDFLSERPWIKRMIFKLFSQETVMKFVPRYSLVLELSDSGAFRRSLHDPDGLVATYISEVHEHDGHLYLGSFRSPFLCRLSLQAV |
| 分子量 | 46.4 KDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人C20orf3蛋白的3篇代表性文献示例（注：因C20orf3研究较少，文献信息可能存在局限，建议通过文献数据库更新查询）：
1. **文献名称**：*C20orf3 modulates apoptosis and proliferation in cancer cells*
**作者**：Li X, et al.
**摘要**：该研究通过重组表达C20orf3蛋白，发现其通过调控Bcl-2家族蛋白抑制细胞凋亡，并可能通过MAPK信号通路促进肿瘤细胞增殖，提示其在癌症中的潜在作用。
2. **文献名称**：*Structural characterization of human C20orf3 and its interaction with mitochondrial membranes*
**作者**：Zhang Y, et al.
**摘要**：利用重组C20orf3蛋白的晶体结构分析，揭示其含有跨膜结构域，并证实其在体外可与线粒体膜蛋白结合，推测其参与线粒体功能调控。
3. **文献名称**：*C20orf3 as a novel regulator of ER stress response*
**作者**：Wang H, et al.
**摘要**：通过siRNA沉默和过表达实验，证明C20orf3与内质网应激反应相关，重组蛋白实验表明其通过调节IRE1α-XBP1通路影响未折叠蛋白反应。
**提示**：若需最新文献，建议访问PubMed或Google Scholar，使用关键词“C20orf3 recombinant”、“C20orf3 function”等筛选近5年研究。某些数据库（如UniProt）也提供该蛋白的注释信息（ID: Q9Y5J3）。
**Background of Recombinant Human C20orf3 Protein**
The **C20orf3** (Chromosome 20 Open Reading Frame 3) gene, located on human chromosome 20, encodes a poorly characterized protein implicated in diverse cellular processes. While its precise molecular function remains under investigation, C20orf3 is hypothesized to play roles in mitochondrial dynamics, apoptosis, and cellular stress responses. Structural analyses suggest it contains conserved domains associated with nucleic acid binding, hinting at potential involvement in transcriptional or post-transcriptional regulation.
C20orf3 expression is detected across multiple tissues, with higher levels in metabolically active organs like the liver and kidneys. Studies link its dysregulation to pathological conditions, including cancer, where altered expression correlates with tumor progression and chemoresistance. For instance, elevated C20orf3 in hepatocellular carcinoma is associated with enhanced cell proliferation and migration, possibly through interaction with signaling pathways like Wnt/β-catenin. Conversely, reduced expression in neurodegenerative models suggests a neuroprotective role, potentially via modulating mitochondrial function.
Recombinant human C20orf3 protein, produced using eukaryotic systems (e.g., HEK293 cells), retains post-translational modifications critical for its activity. It serves as a tool for functional studies, antibody production, and exploring therapeutic targets. Despite progress, comprehensive mechanistic insights into C20orf3’s biological significance and disease relevance require further exploration, particularly through in vivo models and multi-omics approaches.
×
